Mounjaro 10 mg KwikPen | Tirzepatide Injection Product Information
Product Details
Product Name: Mounjaro 10 mg KwikPen
Active Ingredient: Tirzepatide
Strength: 10 mg per dose
Dosage Form: Solution for Injection
Brand Name: Mounjaro KwikPen
Route of Administration: Subcutaneous injection
Pen Type: Pre-filled injection pen
Doses per Pen: 4 doses per pen for the multi-dose KwikPen presentation
Dose Volume: 0.5 mL per injection, as indicated on the packaging
Dosing Frequency: Once weekly, as prescribed
Manufacturer: Eli Lilly
Prescription Status: Prescription medicine
About Mounjaro 10 mg KwikPen
Mounjaro 10 mg KwikPen contains tirzepatide, a dual GIP and GLP-1 receptor agonist used for approved indications, including improving blood sugar control in adults with type 2 diabetes. Depending on the country and product authorization, tirzepatide may also be prescribed for weight management.
Tirzepatide works by activating GIP and GLP-1 receptors, which help regulate blood glucose, appetite and food intake.
The 10 mg strength may be prescribed when a patient requires a higher dose following gradual dose escalation. The appropriate dose depends on individual response, tolerance and the healthcare professional's treatment plan.
Important Safety Information
Use Mounjaro only as prescribed by a qualified healthcare professional.
Administer the injection subcutaneously according to the official product instructions.
Common side effects include nausea, vomiting, diarrhoea, constipation, abdominal discomfort and reduced appetite.
Inform your doctor if you have a history of pancreatitis, gallbladder disease or severe gastrointestinal problems.
The risk of hypoglycaemia may increase when Mounjaro is used with insulin or sulfonylureas.
Discuss your medical history and other medicines with your healthcare professional before treatment.
Follow the official instructions for pen preparation, storage, injection and disposal.
Seek urgent medical attention for severe persistent abdominal pain or symptoms of a serious allergic reaction.
Frequently Asked Questions
1. What is Mounjaro 10 mg KwikPen used for?
Mounjaro contains tirzepatide and is used for approved indications such as blood sugar control in adults with type 2 diabetes. In some countries, it is also approved for weight management.
2. How many doses are in a Mounjaro 10 mg KwikPen?
The multi-dose KwikPen presentation shown is designed to deliver four weekly doses of 10 mg each.
3. How often is Mounjaro 10 mg administered?
It is generally administered once weekly, following the prescription and official product instructions.
4. Can treatment start directly at 10 mg?
Treatment generally begins at a lower dose and increases gradually under medical supervision. Do not start at 10 mg unless your healthcare professional has prescribed it.
5. Does Mounjaro 10 mg KwikPen require a prescription?
Yes. Mounjaro is a prescription medicine and should be used under medical supervision.
Instant Support – Call / WhatsApp Now
For product information and pharmaceutical supply enquiries, contact our team.
Call: +91 8007161282
Call: +91 9970011496
WhatsApp: https://wa.me/918007161282
